 |
|
|
Advisory Committee on Immunization Practices |
|
| FROM THE CENTERS FOR DISEASE CONTROL AND PREVENTION |
|
ACIP Recommendations: Chronological |
|
|
| |
|
|
|
|
|
Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older — United States, 2023
Source: MMWR, February 10, 2023 / 72(6);141–144 |
| HTML | PDF |
| |
Advisory Committee on Immunization Practices Recommended Immunization Schedule for Children and Adolescents Aged 18 Years or Younger — United States, 2023
Source: MMWR, February 10, 2023 / 72(6);137–140 |
| HTML | PDF |
| |
|
|
|
|
|
|
Measles, Mumps, Rubella Vaccine (PRIORIX): Recommendations of the Advisory Committee on Immunization Practices — United States, 2022
Source: MMWR, November 18, 2022, 71 (46); 1465-1470 |
| HTML | PDF |
| |
ACIP interim recommendations for the use of bivalent booster doses of COVID-19 vaccines, US October 2022
Source: MMWR, November 11, 2022, 71(45);1436-1441 |
| HTML | PDF |
| |
Cholera Vaccine: Recommendations of the Advisory Committee on Immunization Practices, 2022
Source: MMWR, September 30, 2022, 71 (2); 1-8 |
| HTML | PDF |
| |
Use of 15-Valent Pneumococcal Conjugate Vaccine Among U.S. Children: Updated Recommendations of the Advisory Committee on Immunization Practices-US, 2022
Source: MMWR, September 16, 2022, 71(37);1174–1181 |
| HTML | PDF |
| |
Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices — United States, 2022–23 Influenza Season
Source: MMWR, August 26, 2022, 71(1); 1-28 |
| HTML | PDF |
| |
ACIP Interim Recommendation for Use of the Novavax COVID-19 Vaccine in Adults 18 years and older — US, July 2022
Source: MMWR, August 5, 2022, 71(31);988–992 |
| HTML | PDF |
| |
ACIP Interim Recommendations for Use of Moderna and Pfizer-BioNTech COVID-19 Vaccines in Children Aged 6 Months–5 Years — United States, June 2022
Source: MMWR Early Release June 28, 2022 |
| HTML | PDF |
| |
Use of Jynneos (smallpox and monkeypox vaccine, live, nonreplicating) for preexposure vaccination of persons at risk for occupational exposure to orthopoxviruses: Recommendations of the Advisory Committee on Immunization Practices — US, 2022
Source: MMWR, May 27, 2022, Vol 71 |
| HTML | PDF |
| |
Use of a Modified Preexposure Prophylaxis Vaccination Schedule to Prevent Human Rabies: Recommendations of the Advisory Committee on Immunization Practices — US, 2022
Source: MMWR, May 6, 2022, 71(18);619–627 |
| HTML | PDF |
| |
Universal Hepatitis B Vaccination in Adults Aged 19–59 Years, updated ACIP recommendations
Source: MMWR, April 1, 2022, 71(13);477–483 |
| HTML | PDF |
| |
ACIP Recommendation for use of Moderna COVID-19 Vaccine in Adults aged 18 years and older, considerations for extended intervals for primary series doses of mRNA COVID-19 vaccines — US, February 2022
Source: MMWR, March 18, 2022, 71 (11); 416-421 |
| HTML | PDF |
| |
Use of Ebola Vaccine: Expansion of ACIP Recommendations to include two additional populations, US, 2021
Source: MMWR, February 25, 2022, 71(8);290–292 |
| HTML | PDF |
| |
Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older — United States, 2022
Source: MMWR, February 18, 2022, 71(7); 229-233 |
| HTML | PDF |
| |
Advisory Committee on Immunization Practices Recommended Immunization Schedule for Children and Adolescents Aged 18 Years or Younger — United States, 2022
Source: MMWR, February 18, 2022, 71(7); 234-237 |
| HTML | PDF |
| |
Use of 15-Valent Pneumococcal Conjugate Vaccine and 20-Valent Pneumococcal Conjugate Vaccine Among U.S. Adults: Updated Recommendations of the Advisory Committee on Immunization Practices
Source: MMWR, January 28, 2022, 71 (4); 109-117 |
| HTML | PDF |
| |
ACIP Updated Interim Recommendations for Use of the Janssen (Johnson & Johnson) COVID-19 vaccine, US, December 2021
Source: MMWR, January 21, 2022, 71(3);90-95 |
| HTML | PDF |
| |
ACIP Recommendations for Use of Recombinant Zoster Vaccine (RZV, Shingrix, GSK) in Immunocompromised Adults aged 19 years and older, US, 2022
Source: MMWR, January 21, 2022, 71(3);80-84 |
| HTML | PDF |
| |
|
|
|
|
ACIP Recommendations on Dengue Vaccine, US, 2021
Source: MMWR December 17, 2021, 70(6);1–16 |
|
|
HTML | PDF |
|
ACIP Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine in Children Aged 5–11 Years - US, 2021
Source: MMWR Early Release November 5, 2021, 70 |
|
|
HTML | PDF |
|
Use of Pfizer-BioNTech COVID-19 Vaccine in Persons Aged 16 Years and older: Recommendations of the Advisory Committee on Immunization Practices — U.S., September 2021
Source: MMWR Early Release, September 21, 2021 |
|
|
HTML | PDF |
|
Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from ACIP — US, July 2021
Source: MMWR, August 13, 2021, 70(32);1094-1099 |
|
|
HTML | PDF |
|
Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices — United States,
2021–22 Influenza Season
Source: MMWR, August 27, 2021, 70(5); 1–28 |
|
|
HTML | PDF |
|
Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from ACIP — US, June 2021
Source: MMWR Early Release, July 6, 2021 |
|
|
HTML | PDF |
|
ACIP Interim Recommendations for use of Pfizer-BioNTech COVID-19 Vaccine in Adolescents Aged 12–15 years, US, May 2021
MMWR Early Release, May 14, 2021, 70 |
|
|
HTML | PDF |
|
Updated Recommendation from ACIP for Use of Janssen (Johnson & Johnson) COVID-19 Vaccine After Reports of Thrombosis with Thrombocytopenia
Syndrome Among Vaccine Recipients — U.S. April 2021
Source: MMWR Early Release, April 27, 2021, 70 |
|
|
HTML | PDF |
|
ACIP Interim Recommendation for Use of Janssen (Johnson and Johnson) COVID-19 Vaccine — U.S., February 2021
Source: MMWR, March 2, 2021, 70 |
|
|
HTML | PDF |
|
Advisory Committee on Immunization Practices Recommended Immunization Schedule for Children and Adolescents Aged 18 Years or Younger — United States, 2021
Source: MMWR, February 12, 2021, 70(6); 189–192 |
|
|
HTML | PDF |
|
Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older — United States, 2021
Source: MMWR, February 12, 2021, 70(6); 193–196 |
|
|
HTML | PDF |
|
Use of Ebola Vaccine: Recommendations of the Advisory Committee on Immunization Practices, U.S., 2020
Source: MMWR, January 8, 2021,70(1);1–12 |
|
|
HTML | PDF |
|
| |
|
|
|
ACIP Updated Interim Recommendation for Allocation of COVID-19 Vaccine – U.S., December 2020
Source: MMWR, December 22, 2020, 69 |
|
|
HTML | PDF |
|
ACIP Interim Recommendation for Use of Moderna COVID-19 Vaccine – U.S, December 2020
Source: MMWR, December 20, 2020, 69 |
|
|
HTML | PDF |
|
ACIP Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine – U.S., December 2020
Source: MMWR, December 13, 2020, 69 |
|
|
HTML | PDF |
|
ACIP Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine – U.S., December 2020
Source: MMWR, December 13, 2020, 69 |
|
|
HTML | PDF |
|
ACIP Interim Recommendation for Allocating Initial Supplies of COVID-19 Vaccine – U.S., 2020
Source: MMWR, December 3, 2020, 69 |
|
|
HTML | PDF |
|
Meningococcal Vaccination: Recommendations of the Advisory Committee on Immunization Practices
Source: MMWR, September 25, 2020, Volume 69(9); 1–41 |
|
|
HTML | PDF |
|
Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices — United States, 2020–21 Influenza Season
Source: MMWR, August 21, 2020, 69 (8); 1–24 |
|
|
HTML | PDF |
|
Prevention of Hepatitis A Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices
Source: MMWR, July 3, 2020, Vol 69 (5);1-38 |
|
|
HTML | PDF |
|
Advisory Committee on Immunization Practices Recommended Immunization Schedule for Children and Adolescents Aged 18 Years or Younger — United States, 2020
Source: MMWR, February 7, 2020, 69 (5);130-132 |
|
|
HTML | PDF |
|
Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older — United States, 2020
Source: MMWR, February 7, 2020, 69 (5);133-135 |
|
|
HTML | PDF |
|
Licensure of a Diphtheria and Tetanus Toxoids and Acellular Pertussis, Inactivated Poliovirus, Haemophilus influenzae Type b Conjugate, and Hepatitis B Vaccine, and Guidance for Use in Infants
Source: MMWR, February 7, 2020, 69 (5);136-139 |
|
|
|
HTML | PDF |
|
Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccines: Updated Recommendations of the Advisory Committee on Immunization Practices
Source: MMWR, January 24, 2020, Vol 69 (3);77-83 |
|
|
HTML | PDF |
|
| |
|
|
|
Use of Anthrax Vaccine in the United States: Recommendations of the Advisory Committee on Immunization Practices, 2019
Source: MMWR, December 13, 2019, 68(4);1–14 |
|
|
HTML | PDF |
|
Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Adults Aged 65 Years and older: Updated Recommendations of the Advisory Committee on Immunization Practices
Source: MMWR, November 22, 2019; 68(46):1069–1075 |
|
|
HTML | PDF |
|
Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices — United States, 2019–20 Influenza Season
Source: MMWR, August 23, 2019, 68(3); 1–21 |
|
|
HTML | PDF |
|
Human Papillomavirus Vaccination for Adults: Updated Recommendations of the Advisory Committee on Immunization Practices
Source: MMWR August 16, 2019; 68(32): 698–702 |
|
|
HTML | PDF |
|
Japanese Encephalitis Vaccine: Recommendations of the Advisory Committee on Immunization Practices
Source: MMWR, July 19, 2019, 68(2); 1-33 |
|
|
HTML | PDF |
|
Recommendations of the Advisory Committee on Immunization Practices for Use of Hepatitis A Vaccine for Persons Experiencing Homelessness
Source: MMWR, February 15, 2019; 68(6);153–156 |
|
|
HTML | PDF |
|
Advisory Committee on Immunization Practices Recommended Immunization Schedule for Children and Adolescents Aged 18 Years or Younger — United States, 2019
Source: MMWR, February 8, 2019, 68 (5);112–114 |
|
|
HTML | PDF |
|
Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older — United States, 2019
Source: MMWR, February 8, 2019, 68 (5);115–118 |
|
|
HTML | PDF |
|
| |
|
|
|
Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices - United States, 2018–19 Influenza Season
Source: MMWR, August 24, 2018, 67(3); 1-20 |
|
|
HTML | PDF |
|
Update: ACIP Recommendations for the Use of Quadrivalent Live Attenuated Influenza Vaccine (LAIV4) — United States, 2018–19 Influenza Season
Source: MMWR, June 8, 2018; 67 (22); 643–645 |
|
|
HTML | PDF |
|
Prevention of Pertussis, Tetanus, and Diphtheria with Vaccines in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
Source: MMWR, April 27, 2018; 67 (2):1-44 |
|
|
HTML | PDF |
|
Recommendations of the Advisory Committee on Immunization Practices for Use of a Hepatitis B Vaccine with a Novel Adjuvant
Source: MMWR, April 20, 2018; 67 (15): 455-458 |
|
|
HTML | PDF |
|
Advisory Committee on
Immunization Practices Recommended Immunization Schedule for
Children and Adolescents Aged 18 Years or Younger — United
States, 2018
Source: MMWR, February 6, 2018; 67 |
|
|
HTML | PDF |
Advisory Committee on
Immunization Practices Recommended Immunization Schedule for
Children and Adolescents Aged 18 Years or Younger — United
States, 2018
Source: MMWR, February 6, 2018;
67 |
|
|
HTML | PDF |
Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older — United States, 2018
Source: MMWR, February 6, 2018; 67 |
|
|
HTML | PDF |
Recommendations of the Advisory Committee on Immunization Practices for Use of Herpes Zoster Vaccines
Source: MMWR, January 26, 2018; 67(3); 103–108 |
|
|
HTML | PDF |
Prevention of Hepatitis B Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices
Source: MMWR, January 12, 2018; 67(1); 1–31 |
|
|
HTML | PDF |
Recommendations of the Advisory Committee on Immunization Practices for Use of a Third Dose of Mumps Virus-Containing Vaccine in Persons at Increased Risk for
Mumps During an Outbreak
Source: MMWR, January 12, 2018; 67(1); 33–37 |
|
|
HTML | PDF |
|
| |
|
|
|
Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices — United States, 2017–18
Influenza Season
Source: MMWR, August 25, 2017, 66(2); 1–20 |
|
|
HTML | PDF |
Updated Recommendations for Use of MenB-FHbp Serogroup B (Trumenba) Meningococcal Vaccine
Source: MMWR, May 19, 2017; 66(19); 509-513 |
|
|
HTML | PDF |
Recommendations of the Advisory Committee on Immunization Practices for Use of Cholera Vaccine
Source: MMWR, May 12, 2017; 66 (18); 482-485 |
|
|
HTML | PDF |
General Best Practice Guidelines for Immunization: Best Practices Guidance of the Advisory Committee on Immunization Practices
Source: CDC website 4/20/17 (this is the original publication date - guidelines are updated by CDC as needed) |
|
|
HTML | PDF |
Advisory Committee on Immunization Practices Recommended Immunization Schedule for Children and Adolescents Aged 18 Years or Younger — United States, 2017
Source: MMWR, February 10, 2017;
66 (5); 134-135 |
|
|
HTML | PDF |
Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older — United States, 2017
Source: MMWR, February 10, 2017; 66 (5); 136-138 |
|
|
HTML | PDF |
Guidance for Assessment of
Poliovirus Vaccination Status and Vaccination of Children Who
Have Received Poliovirus Vaccine Outside the United States
Source: MMWR, January 13, 2017; 66(01); 23–25
(Not an ACIP statement but an important document from CDC.) |
|
|
HTML | PDF |
|
| |
|
|
|
Use of a 2-Dose Schedule for Human Papillomavirus Vaccination -Updated Recommendations of the Advisory Committee on Immunization Practices
Source: MMWR, December 16, 2016; 65(49);1405-8 |
|
|
HTML | PDF |
Recommendations for Use of Meningococcal Conjugate Vaccines in HIV-Infected Persons – Advisory Committee on Immunization Practices (ACIP), 2016
Source: MMWR, November 4, 2016, 65(43);1189–1194 |
|
|
HTML | PDF |
Prevention and Control of
Seasonal Influenza with Vaccines: Recommendations of the
Advisory Committee on Immunization Practices, United States,
2016–17 Influenza Season
Source: MMWR, August 26, 2016, 65(5):1-54 |
|
|
HTML | PDF |
Use of Vaccinia Virus
Smallpox Vaccine in Laboratory and Health Care Personnel at
Risk for Occupational Exposure to Orthopoxviruses—Recommendations
of the Advisory Committee on Immunization Practices (ACIP),
2015
Source: MMWR, March 18, 2016, 65(10):257-262 |
|
|
HTML | PDF |
Advisory Committee on
Immunization Practices Recommended Immunization Schedules for
Persons Aged 0 Through 18 Years — United States, 2016
Source: MMWR, February 2, 2016; 65(4):1-2 |
|
|
HTML | PDF |
Advisory Committee on
Immunization Practices Recommended Immunization Schedule for
Adults Aged 19 Years or Older — United States, 2016
Source: MMWR, February 2, 2016; 65(4):1-3 |
|
|
HTML | PDF |
|
| |
|
|
|
Use of Serogroup B
Meningococcal Vaccines in Adolescents and Young Adults:
Recommendations of the Advisory Committee on Immunization
Practices (ACIP), 2015
Source: MMWR, October 23, 2015; 64(41)1171–1176 |
|
|
HTML | PDF |
Update: Shortened Interval
for Postvaccination Serologic Testing of Infants Born to
Hepatitis B-Infected Mothers
Source: MMWR, October 9,
2015; 64(39):1118-20
(Not an ACIP statement but an important document from CDC.) |
|
|
HTML | PDF |
Intervals Between PCV13 and
PPSV23 Vaccines: Recommendations of the Advisory Committee on
Immunization Practices (ACIP)
Source: MMWR, September 4, 2015; 64(34):944-947 |
|
|
HTML | PDF |
Prevention and Control of
Influenza with Vaccines: Recommendations of the Advisory
Committee on Immunization Practices, United States, 2015–16
Influenza Season
Source: MMWR, August 7, 2015; 64(30):818-825 |
|
|
HTML | PDF |
Yellow Fever Vaccine Booster
Doses: Recommendations of the Advisory Committee on
Immunization Practices, 2015
Source: MMWR, June 19, 2015; 64(23);647-650 |
|
|
HTML | PDF |
Use of Serogroup B
Meningococcal Vaccines in Persons Aged >10 Years at
Increased Risk for Serogroup B Meningococcal Disease:
Recommendations of the Advisory Committee on Immunization
Practices, 2015
Source: MMWR, June 12, 2015; 64(22);608-612 |
|
|
HTML | PDF |
Use of 9-Valent Human Papillomavirus (HPV) Vaccine: Updated HPV Vaccination Recommendations of the Advisory
Committee on Immunization Practices
Source: MMWR, March 27, 2015; 64(11):300-304 |
|
|
HTML | PDF |
Updated Recommendations for the Use of Typhoid Vaccine — Advisory Committee on Immunization Practices, United
States, 2015
Source: MMWR, March 27, 2015; 64(11):305-308 |
|
|
HTML | PDF |
Advisory Committee on
Immunization Practices Recommended Immunization Schedules for
Persons Aged 0 Through 18 Years — United States, 2015
Source: MMWR, February 6, 2015; 64(04):93-94 |
|
|
HTML | PDF |
Advisory Committee on
Immunization Practices Recommended Immunization Schedule for
Adults Aged 19 Years or Older — United States, 2015
Source: MMWR, February 6, 2015; 64(04):91-92 |
|
|
HTML | PDF |
|
| |
|
|
|
Use of 13-Valent
Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal
Polysaccharide Vaccine Among Adults Aged >65 Years:
Recommendations of the
Advisory Committee on Immunization Practices (ACIP)
Source: MMWR, September 19, 2014; 63(37):822-825 |
|
|
HTML | PDF |
Human Papillomavirus
Vaccination: Recommendations of the Advisory Committee on
Immunization Practices (ACIP)
Source: MMWR, August 29, 2014; 63(RR-5):1-30 |
|
|
HTML | PDF |
Update on Recommendations
for Use of Herpes Zoster Vaccine
Source: MMWR, August 22, 2014; 63(33):729-731 |
|
|
HTML | PDF |
Prevention and Control of
Seasonal Influenza with Vaccines: Recommendations of the
Advisory Committee on Immunization Practices — United States,
2014–2015
Source: MMWR, August 15, 2014; 63(327):691–697 |
|
| HTML | PDF |
Use of MenACWY-CRM Vaccine
in Children Aged 2 Through 23 Months at Increased Risk for
Meningococcal Disease
Source: MMWR, June 20, 2014; 63(24):527-530 |
|
|
HTML | PDF |
Prevention and Control of
Haemophilus influenzae Type b Disease: Recommendations
of the Advisory Committee on Immunization Practices (ACIP)
Recommendations and Reports
Source: MMWR, February 28, 2014; 63(RR01):1-14 |
|
|
HTML | PDF |
Advisory Committee on Immunization Practices Recommended Immunization Schedules for Persons Aged 0 Through 18 Years — United States, 2014
Source: MMWR, February 7, 2014; 63(05):108–109 |
|
|
HTML | PDF |
Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older — United States, 2014
Source: MMWR, February 7, 2014; 63(5):110–112 |
|
|
HTML | PDF |
|
| |
|
|
|
CDC Guidance for Evaluating
Health-Care Personnel for Hepatitis B Virus Protection and
for Administering Postexposure Management – Recommendations
and Reports
Source: MMWR, December 20,
2013; 62(rr10);1-19
(Not an ACIP statement but an important document from CDC.) |
|
|
HTML | PDF |
Use of Japanese Encephalitis
Vaccine in Children: Recommendations of the Advisory
Committee on Immunization Practices, 2013
Source: MMWR, November 15, 2013; 62(45):898-900 |
|
|
HTML | PDF |
Prevention and Control of
Seasonal Influenza with Vaccines: Recommendations of the
Advisory Committee on Immunization Practices — United States,
2013–2014
Source: MMWR, September 20, 2013; 62(RR–7):1-48 |
|
|
HTML | PDF |
Updated Recommendations for
Use of VariZIG -- United States, 2013
Source: MMWR, July 19, 2013; 62(28):574-6 |
|
|
HTML | PDF |
Use of 13-Valent Pneumococcal
Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide
Vaccine Among Children Aged 6–18 Years with
Immunocompromising Conditions: Recommendations of the
Advisory Committee on Immunization Practices (ACIP)
Source: MMWR, June 28,
2013; 62(25):521-524 |
|
|
HTML | PDF |
Prevention of Measles,
Rubella, Congenital Rubella Syndrome, and Mumps, 2013 --
Summary Recommendations of the Advisory Committee on
Immunization Practices (ACIP)
Source: MMWR, June 14, 2013; 62(RR04):1-34 |
|
|
HTML | PDF |
Prevention and Control of Influenza with Vaccines: Interim Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2013 Weekly
Source: MMWR, May 10, 2013; 62(18):356 |
|
|
HTML | PDF |
Prevention and Control of
Meningococcal Disease: Recommendations of the Advisory
Committee on Immunization Practices (ACIP)
Source: MMWR, March 22,
2013; 62(RR02):1-22 |
|
|
HTML | PDF |
Updated Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine (Tdap) in Pregnant Women - Advisory Committee
on Immunization Practices (ACIP)
Source: MMWR, February 22, 2013;62(07):131-5 |
|
|
HTML | PDF |
Advisory Committee on
Immunization Practices (ACIP) Recommended Immunization
Schedules for Persons Aged 0 Through 18 years and Adults
Aged 19 Years and Older — United States, 2013
Source: MMWR Supplements, February 1, 2013; 62(01):1-21 |
|
|
HTML | PDF |
Infant Meningococcal
Vaccination: Advisory Committee on Immunization Practices
(ACIP) Recommendations and Rationale
Source: MMWR, January 25,
2013; 62(3):52-4 |
|
|
HTML | PDF |
|
| |
|
|
|
|
Use of 13-Valent Pneumococcal
Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide
Vaccine for Adults with Immunocompromising Conditions:
Recommendations of the Advisory Committee on Immunization
Practices (ACIP)
Source: MMWR, October 12,
2012; 61(40):816-9 |
|
|
HTML | PDF |
Prevention and Control of Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP)—United States, 2012–13
Influenza Season
Source: MMWR, August 18, 2012;61(32);613-8 |
|
|
HTML | PDF |
Updated CDC Recommendations
for the Management of Hepatitis B Virus–Infected Health-Care
Providers and Students
(Not an ACIP statement
but an important document from CDC.)
Source: MMWR, July 6,
2012; 61(RR03):1-12 |
|
|
HTML | PDF |
Updated Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis (Tdap) Vaccine
in Adults Aged 65 Years and Older — Advisory Committee on Immunization Practices (ACIP), 2012
Source: MMWR, June 29, 2012; 61(25):468-70 |
|
|
HTML | PDF |
Licensure of 13-Valent Pneumococcal Conjugate Vaccine for Adults Aged 50 Years and Older
Source: MMWR, June 1, 2012; 61(21):394-5 |
|
|
HTML | PDF |
Recommended Immunization Schedules for Persons Aged 0 Through 18 Years - United States, 2012
Source: MMWR, February 10, 2012; 61(5):1-4 |
|
|
HTML | PDF
(pages 31–34) |
Recommended Adult
Immunization Schedule — United States, 2012
Source: MMWR, February 3, 2012; 61(4):1-7 |
|
|
HTML | PDF (pages 36–43) |
|
| |
|
|
|
|
Use of Hepatitis B Vaccination for Adults with Diabetes Mellitus: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
Source: MMWR, December 23, 2011; 60(50):1709-11 |
|
| HTML | PDF |
Recommendations on the Use of Quadrivalent Human Papillomavirus Vaccine in Males — Advisory Committee on Immunization Practices (ACIP), 2011
Source: MMWR, December 23, 2011; 60(50):1705-8 |
|
| HTML | PDF |
| |
Immunization of
Health-Care Personnel: Recommendations of the Advisory Committee
on Immunization Practices (ACIP)
Source: MMWR, November 25, 2011; 60(RR07):1-45 |
|
|
HTML | PDF |
Updated Recommendations
for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular
Pertussis Vaccine (Tdap) in Pregnant Women and Persons Who Have or
Anticipate Having Close Contact with an Infant Aged <12 Months --
Advisory Committee on Immunization Practices (ACIP), 2011
Source: MMWR, October 21, 2011; 60(41):1424-1426 |
|
|
HTML | PDF |
Recommendation of the
Advisory Committee on Immunization Practices (ACIP) for Use of
Quadrivalent Meningococcal Conjugate Vaccine (MenACWY-D) Among
Children Aged 9 Through 23 Months at Increased Risk for Invasive
Meningococcal Disease
Source: MMWR, October 14, 2011; 60(40):1391-2 |
|
|
HTML | PDF |
Prevention and Control
of Influenza with Vaccines: Recommendations of the Advisory
Committee on Immunization Practices (ACIP), 2011
Source: MMWR, August 26, 2011; 60(33):1128-1132 |
|
|
HTML | PDF |
Licensure of a Meningococcal
Conjugate Vaccine for Children Aged 2 Through 10 Years and Updated
Booster Dose Guidance for Adolescents and Other Persons at
Increased Risk for Meningococcal Disease — Advisory Committee on
Immunization Practices (ACIP), 2011
Source: MMWR, August 5, 2011;
60(30):1018-1019 |
|
|
HTML | PDF |
Recommendations for Use of a
Booster Dose of Inactivated Vero Cell Culture-Derived Japanese
Encephalitis Vaccine -- Advisory Committee on Immunization
Practices, 2011
Source: MMWR, May 27, 2011;
60(20):661-3 |
|
|
HTML | PDF |
Update on Japanese Encephalitis
Vaccine for Children
Source: MMWR, May 27, 2011; 60(20):664-5 |
|
|
HTML | PDF |
Recommended Immunization
Schedules for Persons Aged 0 Through 18 Years -- United States,
2011
Source: MMWR, February 11,
2011; 60(5):1-4 |
|
|
HTML | PDF (pages
29–32) |
Recommended
Adult Immunization Schedule --- United States, 2011
Source:
MMWR, February 4, 2011; 60(04):1-4 |
|
|
HTML | PDF
(pages 41–44) |
General Recommendations on
Immunization
Source: MMWR, January 28, 2011; 60(RR02):1-60 |
|
|
HTML | PDF |
|
|
|
Updated Recommendations
for Use of Meningococcal Conjugate Vaccines--Advisory Committee on
Immunization Practices (ACIP), 2010
Source: MMWR, January 28, 2011; 60(03):72-76 |
|
|
HTML | PDF |
| |
Antiviral Agents for the
Treatment and Chemoprophylaxis of Influenza
Source: MMWR, January 21, 2011; 60(RR01):1-24 |
|
|
HTML | PDF |
| |
Updated Recommendations for Use of
Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis
(Tdap) Vaccine from the Advisory Committee on Immunization
Practices, 2010
Source: MMWR, January 14, 2011;
60(01):13-15 |
|
|
HTML | PDF |
| |
| For ACIP recommendations
published earlier,
visit this
page. |
|
| This page was updated on February 10, 2023. |
|
| This page was reviewed on February 10, 2023. |
|
|
|
|
|
ACIP Recommendations
Vaccine Information Statements 
IAC Home
